The Chemistry Department at The Wertheim UF Scripps Institute brings gifted thinkers together to advance science and solve urgent biomedical problems.
We work broadly at the forefront of chemical biology, with experts in the areas of synthesis, enzyme catalysis, RNA chemical biology, natural product biosynthesis, redox biochemistry, transcription factor biology, photochemistry and DNA-encoded chemistries. We collaborate daily with structural, micro- and cellular biologists to improve the human condition. We seek original thinkers who would push the boundaries of human knowledge at the interface of chemistry and biology.
The department focuses on several research areas, including:
- Searching for new therapies for diseases, including cancer, Alzheimer’s and other neurodegenerative disorders, HIV-AIDS and other viral diseases, and tuberculosis and other bacterial infections
- Developing new technologies for RNA evolution, DNA sequencing, nanomedicine and stem cell research
- Creating state-of-the-art tools to design, synthesize and evaluate new functional molecules for specific applications
- Synthesizing natural products and their designed analogs, as well as natural product discovery and biosynthesis
Graduate students at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology earn their Ph.D. from the Skaggs Graduate School of Chemical and Biological Sciences at Scripps Research in La Jolla, California, while having access to outstanding clinical, research and academic expertise at the University of Florida. Learn more about our graduate program.
The chemists of The Wertheim UF Scripps Institute have been making major discoveries in the field for nearly two decades. Read about many of them here.
Our faculty have expertise in natural products chemistry, RNA biochemistry, enzyme catalysis, organic synthesis, redox biochemistry, transcription factor biology, DNA-encoded chemistries and more.
Our focus is translating sequence into lead small-molecule RNA therapeutics for undruggable and incurable diseases.